Posts tagged as:

IVO

After a summer slowdown that saw the pace of new ETF launches decline dramatically, product development in the industry ramped up in September. The end of vacation season brought a wave of new exchange-traded products to market, including several first-to-market concepts and the introduction of a couple of new issuers.

September also saw a continuation of a more recent trend: fund closures. A handful of issuers announced last month that they would be shuttering products, including the departure from the industry for one firm. [click to continue…]

{ Comments on this entry are closed }

iPath Debuts IVO Successor

by on September 20, 2011

After announcing the automatic termination last week of the Inverse January 2021 S&P 500 VIX Short-Term Futures ETN (IVO), iPath was quick to roll out a successor fund that will maintain a generally similar investment objective. Monday marked the first day of trading for the Inverse S&P 500 VIX Short-Term Futures ETN (IVOP), which will offer inverse exposure to an index comprised of daily rolling positions in first and second month VIX futures contracts. 

The new ETN will mature in September 2021, and will also feature an automatic redemption trigger at $10 per share (shares in IVOP began trading at $20). IVO hit the $10 level last week, triggering a redemption of the notes by Barclays. Earlier this year, Barclays also redeemed its Long Enhanced S&P 500 VIX Mid-Term Futures ETN (VZZ) and subsequently issued VZZB, which offers generally similar exposure. [click to continue…]

{ Comments on this entry are closed }

Trading in the iPath Inverse January 2021 S&P 500 VIX Short-Term Futures ETN (IVO) was suspended on Monday after the note’s indicative value hit the automatic termination level of $10.00 per share. IVO, which offers inverse exposure to an index comprised of VIX futures contracts, tumbled in Monday morning trading as anxiety over the Greek […]

{ Comments on this entry are closed }

Inverse VIX ETNs: Reviewing All The Options

by on June 23, 2011 | Updated December 8, 2014

As the lineup of ETFs approaches the 1,450 mark, a growing pool of issuers continue to deliver innovative new products that tap into strategies and asset classes that have never before been accessible through the exchange-traded structure. One relatively new area that has attracted billions of dollars in new assets in recent years is the […]

{ 0 comments }

After a quiet stretch during the second half of December, January continued the wave of product innovation that has become common in the ETF industry. Various issuers introduced first-to-market products and continued the impressive expansion of the exchange-traded product pipeline. The month saw steady releases from various issuers to add to the 1,100+ exchange traded […]

{ Comments on this entry are closed }

iPath Adds Another Volatility ETN (IVO)

by on January 20, 2011 | Updated January 25, 2011

iPath has launched another exchange-traded note offering inverse exposure to an index comprised of VIX-related futures contracts, rolling out the January 2021 Inverse S&P 500 VIX Short-Term Futures ETN (IVO). The new product is substantially similar to the Inverse S&P 500 VIX Short-Term Futures ETN (XXV) that launched in July of last year; both ETNs […]

{ Comments on this entry are closed }